Colesevelam and gliptin therapies have proven effective in regulating blood glucose and cholesterol levels in patients with type 2 diabetes, and some preliminary data indicate that these treatments may also have benefits for some patients with type 1 diabetes, according to Dr. Steven V. Edelman, a professor of medicine at the University of California, San Diego.

Related Summaries